Latest total assets for HMGN: $2.4M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2012), HMGN shows a total assets of $2.4M. That compares with $2.9M in the prior-year period — down 15.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HMGN's total assets is now $2.4M (was $2.9M) — a 15.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Hemagen Diagnostics is outperforming or lagging.
Tracking HMGN's total assets over time shows whether Hemagen Diagnostics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4M That compares with $2.9M in the prior-year period — down 15.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has Hemagen Diagnostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $2.4M) with ownership activity and broader fundamentals.
Hemagen Diagnostics's total assets is $2.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.